No abstract available
MeSH terms
-
Antiviral Agents / therapeutic use
-
COVID-19 Testing
-
COVID-19 Vaccines / immunology*
-
COVID-19* / diagnosis
-
COVID-19* / immunology
-
COVID-19* / prevention & control
-
COVID-19* / transmission
-
Disease Transmission, Infectious / prevention & control*
-
Drug Development
-
Health Personnel
-
Health Services Accessibility*
-
Healthcare Disparities
-
Humans
-
Patient Acuity*
-
Public Health
-
Recurrence
-
Spike Glycoprotein, Coronavirus / immunology
-
Time Factors
-
Vaccine Development
-
Vaccine Efficacy
Substances
-
Antiviral Agents
-
COVID-19 Vaccines
-
Spike Glycoprotein, Coronavirus
-
spike protein, SARS-CoV-2